Evidence map›Paper›PMID 30136163›Full record

ArticleEJNMMI research2018

Radiomics of the primary tumour as a tool to improve

Elisabetta De Bernardi, Alessandro Buda, Luca Guerra, Debora Vicini, Federica Elisei, Claudio Landoni, Robert Fruscio, Cristina Messa, Cinzia Crivellaro

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in EJNMMI research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05056259 (Usefulness of 18F-FDG PET/CT in the Initial Staging and Surveillance of Endometrial Cancer Patients), which is not on this map. Cited by 27 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 3 pooled it
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05056259 unknown statusnot on this mapstarted 2022, after this paper: background citation

Usefulness of 18F-FDG PET/CT in the Initial Staging and Surveillance of Endometrial Cancer Patients

TypeobservationalSponsorAssiut UniversityRan2022 to 2023Enrolled42ConditionsEndometrial CancerArms18F-FDG PET/CT
3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 3 syntheses or guidelines pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Predicting aggressive disease and poor outcome in endometrial cancer using preoperative [European journal of nuclear medicine and molecular imaging · 2025
    Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Radiomics in cervical and endometrial cancer.The British journal of radiology · 2021
    Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Elisabetta De BernardiMedicine and Surgery Department, University of Milano Bicocca, via Cadore 48, 20900, Monza, MB, Italy. elisabetta.debernardi@unimib.it.ORCID http://orcid.org/0000-0002-8394-0342
Alessandro BudaClinic of Obstetrics and Gynaecology, San Gerardo Hospital, via Pergolesi 33, 20900, Monza, MB, Italy.
Luca GuerraNuclear Medicine Department, San Gerardo Hospital, via Pergolesi 33, 20900, Monza, MB, Italy.
Debora ViciniClinic of Obstetrics and Gynaecology, San Gerardo Hospital, via Pergolesi 33, 20900, Monza, MB, Italy.
Federica EliseiNuclear Medicine Department, San Gerardo Hospital, via Pergolesi 33, 20900, Monza, MB, Italy.
Claudio LandoniMedicine and Surgery Department, University of Milano Bicocca, via Cadore 48, 20900, Monza, MB, Italy.
Robert FruscioMedicine and Surgery Department, University of Milano Bicocca, via Cadore 48, 20900, Monza, MB, Italy.
Cristina MessaMedicine and Surgery Department, University of Milano Bicocca, via Cadore 48, 20900, Monza, MB, Italy.
Cinzia CrivellaroMedicine and Surgery Department, University of Milano Bicocca, via Cadore 48, 20900, Monza, MB, Italy.
Azienda Ospedaliera San Gerardo · ITUniversity of Milano-Bicocca · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA radiomic approach was applied in 18F-FDG PET endometrial cancer, to investigate if imaging features computed on the primary tumour could improve sensitivity in nodal metastases detection. One hundred fifteen women with histologically proven endometrial cancer who underwent preoperative 18F-FDG PET/CT were retrospectively considered. SUV, MTV, TLG, geometrical shape, histograms and texture features were computed inside tumour contours. On a first group of 86 patients (DB1), univariate association with LN metastases was computed by Mann-Whitney test and a neural network multivariate model was developed. Univariate and multivariate models were assessed with leave one out on 20 training sessions and on a second group of 29 patients (DB2). A unified framework combining LN metastases visual detection results and radiomic analysis was also assessed.

resultsSensitivity and specificity of LN visual detection were 50% and 99% on DB1 and 33% and 95% on DB2, respectively. A unique heterogeneity feature computed on the primary tumour (the zone percentage of the grey level size zone matrix, GLSZM ZP) was able to predict LN metastases better than any other feature or multivariate model (sensitivity and specificity of 75% and 81% on DB1 and of 89% and 80% on DB2). Tumours with LN metastases are in fact generally characterized by a lower GLSZM ZP value, i.e. by the co-presence of high-uptake and low-uptake areas. The combination of visual detection and GLSZM ZP values in a unified framework obtained sensitivity and specificity of 94% and 67% on DB1 and of 89% and 75% on DB2, respectively.

conclusionsThe computation of imaging features on the primary tumour increases nodal staging detection sensitivity in 18F-FDG PET and can be considered for a better patient stratification for treatment selection. Results need a confirmation on larger cohort studies.

Indexed as

18F-FDG PETEndometrial cancerNodal stage assessmentPET radiomicsTexture analysis

Identifiers

PMID30136163
PMCPMC6104464
OpenAlexW2888082487

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.